Tai-Yin Wu

Dr. Tai-Yin Wu

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
TWTai-Yin Wu
Tai-Yin Wu
CLChen-Kun Liaw
Chen-Kun Liaw
FCFang-Chun Chen
Fang-Chun Chen
KKKuan-Liang Kuo
Kuan-Liang Kuo
WCWei-Chu Chie
Wei-Chu Chie
RYRong-Sen Yang
Rong-Sen Yang

31 August 2022 in Indian Journal of Dermatology, Venereology and Leprology
Verified
Journal Article
Open access
WWWei-Jen Wang
Wei-Jen Wang
TWTai-Yin Wu
Tai-Yin Wu
YTYu-Kang Tu
Yu-Kang Tu
KKKuan-Liang Kuo
Kuan-Liang Kuo
CTChing-Yao Tsai
Ching-Yao Tsai
WCWei-Chu Chie
Wei-Chu Chie
Background: Melasma is a chronic skin condition that adversely impacts quality of life. Although many therapeutic modalities are available there is no single best treatment for melasma. Oral tranexamic acid has been used for the treatment of this condition but its optimal dose is yet to be established.Objectives: We used network meta-analysis to determine the optimal dose of oral tranexamic acid for the treatment of melasma.Methods: We conducted a comprehensive search of all studies of oral tranexamic acid for the treatment of melasma up to September 2020 using PubMed, EMBASE and the Cochrane Library database. The quality of the studies was evaluated using the Jadad score and the Cochrane’s risk of bias assessment tool. Only high quality randomised controlled trials were selected. Some studies lacked standard deviation of changes from baseline and these were estimated using the correlation coefficient obtained from another similar study.Results: A total of 92 studies were identified of which 6 randomized controlled trials comprising 599 patients were included to form 3 pair-wise network comparisons. The mean age of the patients in these studies ranged from 30.3 to 46.5 years and the treatment duration ranged from 8 to 12 weeks. The Jadad scores ranged from 5 to 8.The optimal dose and duration of oral tranexamic acid was estimated to be 750 mg per day for 12 consecutive weeks.Limitations: Some confounding factors might not have been described in the original studies. Although clear rules were followed, the Melasma Area and Severity Index and the modified Melasma Area and Severity Index were scored by independent physicians and hence inter-observer bias could not be excluded.Conclusion: Oral tranexamic acid is a promising drug for the treatment of melasma. This is the first network meta-analysis to determine the optimal dose of this drug and to report the effects of different dosages. The optimal dose is 250 mg three times per day for 12 weeks, but 250 mg twice daily may be an acceptable option in poorly adherent patients. Our findings will allow physicians to balance drug effects and medication adherence. Personalized treatment plans are warranted.

6 January 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MLMin-Chang Lee
Min-Chang Lee
TWTai-Yin Wu
Tai-Yin Wu
YCYa-Mei Chen
Ya-Mei Chen
SHSheng-Huang Hsiao
Sheng-Huang Hsiao
CTChing-Yao Tsai
Ching-Yao Tsai
Background: To evaluate the effects of post-acute care (PAC) on frail older adults after acute hospitalization in Taiwan. Methods: This was a multicenter interventional study. Frail patients aged ≥ 75 were recruited and divided into PAC or control group. The PAC group received comprehensive geriatric assessment (CGA) and multifactorial intervention including exercise, nutrition education, and medicinal adjustments for two to four weeks, while the control group received only CGA. Outcome measures included emergency room (ER) visits, readmissions, and mortality within 90 days after PAC. Results: Among 254 participants, 205 (87.6±6.0 years) were in the PAC and 49 (85.2±6.0 years) in the control group. PAC for more than two weeks significantly decreased 90-day ER visits (odds ratio [OR] 0.21, 95% confidence interval [CI] 0.10–0.43; p = 0.024), readmissions (OR 0.30, 95% CI 0.16–0.56; p < 0.001), and mortality (OR 0.20, 95% CI 0.04–0.87; p = 0.032). Having problems in self-care was an independent risk factor for 90-day ER visits (OR 2.11, 95% CI 1.17–3.78; p = 0.012), and having problems in usual activities was an independent risk factor for 90-day readmissions (OR 2.69, 95% CI 1.53–4.72; p = 0.001) and mortality (OR 3.16, 95% CI 1.16–8.63; p = 0.024). Conclusion: PAC program for more than two weeks could have beneficial effects on decreasing ER visits, readmissions, and mortality after an acute illness in frail older patients. Those who perceived severe problems in self-care and usual activities had a higher risk of subsequent adverse outcomes. Trial registration: ClinicalTrials.gov NCT Identifier: NCT05452395.

30 May 2023 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
JCJer-Min Chen
Jer-Min Chen
TWTai-Yin Wu
Tai-Yin Wu
YWYi-Fan Wu
Yi-Fan Wu
KKKuan-Liang Kuo
Kuan-Liang Kuo
Objective: An increasing amount of literature indicates that the serum calcium level may be related to metabolic syndrome (MetS) and obesity. This study aimed to examine the relationship between the serum calcium level and MetS in adults in Taiwan. Subjects and methods: We conducted a cross-sectional study and enrolled 1,580 participants (54.4% women; mean age, 33.28 ± 12.21 years) who underwent health examinations in northern Taiwan between 2012 and 2016. Logistic regression was performed to estimate the odds ratios [...] ABSTRACT Objective: An increasing amount of literature indicates that the serum calcium level may be related to metabolic syndrome (MetS) and obesity. This study aimed to examine the relationship between the serum calcium level and MetS in adults in Taiwan. Subjects and methods: We conducted a cross-sectional study and enrolled 1,580 participants (54.4% women; mean age, 33.28 ± 12.21 years) who underwent health examinations in northern Taiwan between 2012 and 2016. Logistic regression was performed to estimate the odds ratios

30 June 2021 in Australasian Journal on Ageing
Verified
Journal Article
Closed access
PDF file
HTHsiao‐Ting Tsou
Hsiao‐Ting Tsou
TWTai-Yin Wu
Tai-Yin Wu
KKKuan‐Liang Kuo
Kuan‐Liang Kuo
SHSheng‐Huang Hsiao
Sheng‐Huang Hsiao
CTChing‐Yao Tsai
Ching‐Yao Tsai

27 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KYKuei-Lin Yeh
Kuei-Lin Yeh
TWTai-Yin Wu
Tai-Yin Wu
CFChiou-Shann Fuh
Chiou-Shann Fuh
CCChu-Song Chen
Chu-Song Chen
YCYann-Jang Chen
Yann-Jang Chen
Chen-Kun LiawChen-Kun Liaw
Chen-Kun Liaw
There are many published cup anteversion measurements for postoperative total hip arthroplasty (THA), including Liaw’s, Lewinnek’s, and Murray’s methods. However, most measurements ignore the potential pelvic rotation on radiographs except in Liaw’s method. Without considering pelvic rotation, clinicians can miscalculate cup anteversion. Therefore, we aimed to quantify the mean degree of pelvic rotation. Herein, we collected 388 radiographs of 98 postoperative THA hips of 77 patients and measured pelvic rotation by measuring h, the horizontal displacement of the sacrococcygeal junction associated with the upper pole of the symphysis pubis, and ssd, the distance between the sacrococcygeal junction and pubic symphysis. The angle θ of pelvic rotation was defined as θ = arc sin (h/ssd) × (180°/π). The mean degree of pelvic rotation was then calculated. The standard deviation of h was 7.84 mm, and the mean ssd was 158 mm. The potential pelvic rotation was 2.50°. The p-values from the paired t-test were all >0.05 when interobserver and intraobserver errors were assessed. This is the first study to quantify the potential pelvic rotation in the coronal plane on postoperative plain radiographs. The potential pelvic rotation was too large to be neglected during the measurement of cup anteversion.